{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-015862","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.270581+00:00","generated_at":"2026-06-25T04:58:29.171529+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncotelic issues $605K convertible note to Mast Hill; uses up to $250K to repay prior debt","bullets":["Issued $605,000 convertible promissory note to Mast Hill Fund, LP at 12% interest, convertible at $0.10 per share.","Also issued 3,025,000 warrants with exercise price of $0.20 per share.","Net gross proceeds to company up to $250,000 used to repay prior notes from Talos and FirstFire.","Finder's fee of 10% of gross proceeds and 10% warrant coverage payable to JH Darbie & Co.","Conversion and warrants could cause significant dilution; maturity one year from issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-015862","json":"https://secwatch.observer/filing/0001493152-22-015862.json","markdown":"https://secwatch.observer/filing/0001493152-22-015862.md","text":"https://secwatch.observer/filing/0001493152-22-015862.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315222015862/0001493152-22-015862-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315222015862/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:58:29.171529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}